"Treatment of Nonfatal Conditions at the End of Life 

Nonmelanoma Skin Cancer" 

JAMA IM April 29
http://archinte.jamanetwork.com/article.aspx?articleid=1682360 
"Conclusions and Relevance  Most NMSCs are treated surgically, regardless of the patient's life expectancy. Given the very low tumor recurrence rates and high mortality from causes unrelated to NMSC in patients with LLE, clinicians should consider whether these patients would prefer less invasive treatment strategies."